Impact of PD-L1 Expression and Tumor Microenvironments on Osimertinib Efficacy in Pretreated Non-Small-Cell Lung Cancer Harboring an Acquired EGFRT790M Mutation

Ching‐Yao Yang, Chong‐Jen Yu, Chao‐Chi Ho et al.|SSRN Electronic Journal|2022

Cited by 0